nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Methyldopa—hypertension	0.26	1	CrCtD
Droxidopa—ADRA2B—hypertension	0.0503	0.267	CbGaD
Droxidopa—SLC6A2—hypertension	0.0442	0.235	CbGaD
Droxidopa—ADRA1A—hypertension	0.0312	0.165	CbGaD
Droxidopa—Aminosalicylic Acid—Methyldopa—hypertension	0.0258	0.142	CrCrCtD
Droxidopa—ADRA2A—hypertension	0.0221	0.117	CbGaD
Droxidopa—ADRB1—hypertension	0.022	0.117	CbGaD
Droxidopa—DDC—Methyldopa—hypertension	0.0195	0.074	CbGbCtD
Droxidopa—Carbidopa—Methyldopa—hypertension	0.0194	0.107	CrCrCtD
Droxidopa—ADRB2—hypertension	0.0185	0.0984	CbGaD
Droxidopa—Isoetarine—Methyldopa—hypertension	0.018	0.099	CrCrCtD
Droxidopa—Mesalazine—Methyldopa—hypertension	0.018	0.099	CrCrCtD
Droxidopa—Dopamine—Methyldopa—hypertension	0.0168	0.0924	CrCrCtD
Droxidopa—Norepinephrine—Methyldopa—hypertension	0.0168	0.0924	CrCrCtD
Droxidopa—Levonordefrin—Methyldopa—hypertension	0.0157	0.0867	CrCrCtD
Droxidopa—Epinephrine—Methyldopa—hypertension	0.0127	0.0699	CrCrCtD
Droxidopa—L-DOPA—Methyldopa—hypertension	0.0111	0.0614	CrCrCtD
Droxidopa—ADRB3—Nadolol—hypertension	0.0106	0.0405	CbGbCtD
Droxidopa—ADRB3—Labetalol—hypertension	0.0106	0.0405	CbGbCtD
Droxidopa—Isoprenaline—Methyldopa—hypertension	0.0103	0.0569	CrCrCtD
Droxidopa—ADRB3—Pindolol—hypertension	0.00905	0.0344	CbGbCtD
Droxidopa—Isoprenaline—Pindolol—hypertension	0.00898	0.0495	CrCrCtD
Droxidopa—Isoprenaline—Labetalol—hypertension	0.00796	0.0438	CrCrCtD
Droxidopa—SLC6A2—Guanadrel—hypertension	0.00634	0.0241	CbGbCtD
Droxidopa—ADRB2—Esmolol—hypertension	0.00574	0.0218	CbGbCtD
Droxidopa—ADRB1—Esmolol—hypertension	0.00566	0.0215	CbGbCtD
Droxidopa—ADRB3—Timolol—hypertension	0.0052	0.0198	CbGbCtD
Droxidopa—ADRB3—Carvedilol—hypertension	0.00503	0.0191	CbGbCtD
Droxidopa—SLC6A2—Guanethidine—hypertension	0.0048	0.0183	CbGbCtD
Droxidopa—ADRB3—Propranolol—hypertension	0.00463	0.0176	CbGbCtD
Droxidopa—ADRA2C—Guanabenz—hypertension	0.00455	0.0173	CbGbCtD
Droxidopa—ADRA1D—Terazosin—hypertension	0.00438	0.0167	CbGbCtD
Droxidopa—ADRB2—Nebivolol—hypertension	0.00435	0.0166	CbGbCtD
Droxidopa—ADRB2—Nadolol—hypertension	0.00435	0.0166	CbGbCtD
Droxidopa—ADRB2—Labetalol—hypertension	0.00435	0.0166	CbGbCtD
Droxidopa—ADRA2B—Guanabenz—hypertension	0.00432	0.0164	CbGbCtD
Droxidopa—ADRB1—Labetalol—hypertension	0.00429	0.0163	CbGbCtD
Droxidopa—ADRB1—Nebivolol—hypertension	0.00429	0.0163	CbGbCtD
Droxidopa—ADRB1—Nadolol—hypertension	0.00429	0.0163	CbGbCtD
Droxidopa—ADRA2B—Guanfacine—hypertension	0.00401	0.0153	CbGbCtD
Droxidopa—ADRB2—Acebutolol—hypertension	0.00398	0.0151	CbGbCtD
Droxidopa—ADRA1D—Fenoldopam—hypertension	0.00396	0.0151	CbGbCtD
Droxidopa—ADRB1—Acebutolol—hypertension	0.00392	0.0149	CbGbCtD
Droxidopa—ADRB2—Pindolol—hypertension	0.0037	0.0141	CbGbCtD
Droxidopa—ADRB2—Metoprolol—hypertension	0.0037	0.0141	CbGbCtD
Droxidopa—ADRA1D—Doxazosin—hypertension	0.00366	0.0139	CbGbCtD
Droxidopa—ADRB1—Metoprolol—hypertension	0.00364	0.0139	CbGbCtD
Droxidopa—ADRB1—Pindolol—hypertension	0.00364	0.0139	CbGbCtD
Droxidopa—ADRA2C—Fenoldopam—hypertension	0.0036	0.0137	CbGbCtD
Droxidopa—ADRA2B—Fenoldopam—hypertension	0.00341	0.013	CbGbCtD
Droxidopa—ADRB2—Betaxolol—hypertension	0.0033	0.0125	CbGbCtD
Droxidopa—ADRA2A—Methyldopa—hypertension	0.00328	0.0125	CbGbCtD
Droxidopa—ADRB1—Betaxolol—hypertension	0.00325	0.0124	CbGbCtD
Droxidopa—ADRA1B—Terazosin—hypertension	0.00319	0.0121	CbGbCtD
Droxidopa—ADRA1B—vas deferens—hypertension	0.00311	0.239	CbGeAlD
Droxidopa—ADRB2—Penbutolol—hypertension	0.00302	0.0115	CbGbCtD
Droxidopa—ADRA1D—Prazosin—hypertension	0.003	0.0114	CbGbCtD
Droxidopa—ADRA2A—Guanabenz—hypertension	0.003	0.0114	CbGbCtD
Droxidopa—ADRB1—Penbutolol—hypertension	0.00297	0.0113	CbGbCtD
Droxidopa—ADRA1B—Fenoldopam—hypertension	0.00288	0.011	CbGbCtD
Droxidopa—ADRA2A—Guanfacine—hypertension	0.00279	0.0106	CbGbCtD
Droxidopa—ADRA1B—Doxazosin—hypertension	0.00266	0.0101	CbGbCtD
Droxidopa—ADRA1D—Carvedilol—hypertension	0.00259	0.00985	CbGbCtD
Droxidopa—ADRA1D—Nicardipine—hypertension	0.00259	0.00985	CbGbCtD
Droxidopa—ADRA2B—Prazosin—hypertension	0.00259	0.00983	CbGbCtD
Droxidopa—ADRA1A—Terazosin—hypertension	0.00252	0.00957	CbGbCtD
Droxidopa—ADRA2A—Fenoldopam—hypertension	0.00237	0.00902	CbGbCtD
Droxidopa—ADRA2C—Carvedilol—hypertension	0.00235	0.00895	CbGbCtD
Droxidopa—ADRA1D—Clonidine—hypertension	0.00227	0.00865	CbGbCtD
Droxidopa—ADRA1A—Fenoldopam—hypertension	0.00227	0.00865	CbGbCtD
Droxidopa—ADRA2B—Carvedilol—hypertension	0.00223	0.00849	CbGbCtD
Droxidopa—ADRA2A—Doxazosin—hypertension	0.00219	0.00833	CbGbCtD
Droxidopa—ADRA1B—Prazosin—hypertension	0.00219	0.00831	CbGbCtD
Droxidopa—ADRB2—Timolol—hypertension	0.00213	0.00808	CbGbCtD
Droxidopa—ADRA1A—Doxazosin—hypertension	0.0021	0.00798	CbGbCtD
Droxidopa—ADRB1—Timolol—hypertension	0.00209	0.00796	CbGbCtD
Droxidopa—ADRA2C—Clonidine—hypertension	0.00207	0.00786	CbGbCtD
Droxidopa—ADRB2—Carvedilol—hypertension	0.00206	0.00783	CbGbCtD
Droxidopa—ADRB1—Carvedilol—hypertension	0.00203	0.00771	CbGbCtD
Droxidopa—ADRA2B—Clonidine—hypertension	0.00196	0.00745	CbGbCtD
Droxidopa—ADRB2—Propranolol—hypertension	0.00189	0.0072	CbGbCtD
Droxidopa—ADRA1B—Nicardipine—hypertension	0.00189	0.00717	CbGbCtD
Droxidopa—ADRA1B—Carvedilol—hypertension	0.00189	0.00717	CbGbCtD
Droxidopa—ADRB1—Propranolol—hypertension	0.00187	0.0071	CbGbCtD
Droxidopa—ADRA2A—Prazosin—hypertension	0.0018	0.00684	CbGbCtD
Droxidopa—ADRA1A—Prazosin—hypertension	0.00172	0.00656	CbGbCtD
Droxidopa—ADRA1B—Clonidine—hypertension	0.00166	0.0063	CbGbCtD
Droxidopa—ADRA2A—Carvedilol—hypertension	0.00155	0.0059	CbGbCtD
Droxidopa—SLC6A2—Clonidine—hypertension	0.00151	0.00575	CbGbCtD
Droxidopa—ADRA1A—Carvedilol—hypertension	0.00149	0.00566	CbGbCtD
Droxidopa—ADRA1A—Nicardipine—hypertension	0.00149	0.00566	CbGbCtD
Droxidopa—ADRA2A—Clonidine—hypertension	0.00136	0.00518	CbGbCtD
Droxidopa—ADRA1A—Clonidine—hypertension	0.00131	0.00497	CbGbCtD
Droxidopa—SLC6A2—locus ceruleus—hypertension	0.00108	0.083	CbGeAlD
Droxidopa—SLC6A2—sympathetic nervous system—hypertension	0.000854	0.0656	CbGeAlD
Droxidopa—SLC6A2—autonomic nervous system—hypertension	0.000574	0.0441	CbGeAlD
Droxidopa—PAH—kidney—hypertension	0.000407	0.0313	CbGeAlD
Droxidopa—ADRB2—Treprostinil—Nadolol—hypertension	0.000383	1	CbGdCrCtD
Droxidopa—DDC—brainstem—hypertension	0.000291	0.0224	CbGeAlD
Droxidopa—PAH—endocrine gland—hypertension	0.000286	0.0219	CbGeAlD
Droxidopa—DDC—nephron tubule—hypertension	0.000264	0.0203	CbGeAlD
Droxidopa—PAH—central nervous system—hypertension	0.000257	0.0198	CbGeAlD
Droxidopa—DDC—kidney—hypertension	0.000232	0.0178	CbGeAlD
Droxidopa—DDC—cortex of kidney—hypertension	0.000226	0.0174	CbGeAlD
Droxidopa—ADRB1—cardiac ventricle—hypertension	0.000215	0.0165	CbGeAlD
Droxidopa—ADRB1—myocardium—hypertension	0.000202	0.0155	CbGeAlD
Droxidopa—DDC—adrenal gland—hypertension	0.000188	0.0144	CbGeAlD
Droxidopa—ADRA1B—kidney—hypertension	0.000183	0.0141	CbGeAlD
Droxidopa—SLC16A10—nephron tubule—hypertension	0.000181	0.0139	CbGeAlD
Droxidopa—DDC—endocrine gland—hypertension	0.000163	0.0125	CbGeAlD
Droxidopa—ADRA2C—cardiac ventricle—hypertension	0.000162	0.0124	CbGeAlD
Droxidopa—Mesalazine—IKBKB—hypertension	0.000157	0.0814	CrCbGaD
Droxidopa—SLC16A10—cortex of kidney—hypertension	0.000155	0.0119	CbGeAlD
Droxidopa—ADRA2C—myocardium—hypertension	0.000152	0.0117	CbGeAlD
Droxidopa—DDC—central nervous system—hypertension	0.000147	0.0113	CbGeAlD
Droxidopa—ADRB1—heart—hypertension	0.000141	0.0108	CbGeAlD
Droxidopa—SLC6A2—brainstem—hypertension	0.000139	0.0106	CbGeAlD
Droxidopa—ADRB1—cardiovascular system—hypertension	0.000133	0.0102	CbGeAlD
Droxidopa—ADRA1A—brainstem—hypertension	0.000129	0.0099	CbGeAlD
Droxidopa—Isoprenaline—PIK3R1—hypertension	0.000127	0.0656	CrCbGaD
Droxidopa—ADRA1D—endocrine gland—hypertension	0.000126	0.00965	CbGeAlD
Droxidopa—ADRB1—cardiac atrium—hypertension	0.000121	0.00926	CbGeAlD
Droxidopa—SLC6A2—decidua—hypertension	0.000117	0.00896	CbGeAlD
Droxidopa—ADRA1B—central nervous system—hypertension	0.000116	0.00889	CbGeAlD
Droxidopa—ADRA1D—central nervous system—hypertension	0.000113	0.00869	CbGeAlD
Droxidopa—SLC16A10—endocrine gland—hypertension	0.000112	0.00858	CbGeAlD
Droxidopa—ADRA2C—nephron tubule—hypertension	0.000112	0.00857	CbGeAlD
Droxidopa—ADRA1A—heart—hypertension	0.000111	0.00856	CbGeAlD
Droxidopa—ADRA2C—adrenal cortex—hypertension	0.00011	0.00844	CbGeAlD
Droxidopa—ADRA2C—heart—hypertension	0.000106	0.00816	CbGeAlD
Droxidopa—ADRA1A—cardiovascular system—hypertension	0.000105	0.00808	CbGeAlD
Droxidopa—ADRA2C—decidua—hypertension	0.000103	0.00794	CbGeAlD
Droxidopa—Metaraminol—ADRA1A—hypertension	0.000101	0.0522	CrCbGaD
Droxidopa—ADRA2C—kidney—hypertension	9.81e-05	0.00753	CbGeAlD
Droxidopa—SLC6A2—medulla oblongata—hypertension	9.67e-05	0.00743	CbGeAlD
Droxidopa—ADRA2C—cortex of kidney—hypertension	9.55e-05	0.00734	CbGeAlD
Droxidopa—Isoprenaline—ADRBK1—hypertension	9.17e-05	0.0474	CrCbGaD
Droxidopa—ADRB1—endocrine gland—hypertension	9.12e-05	0.00701	CbGeAlD
Droxidopa—ADRA2C—cardiac atrium—hypertension	9.08e-05	0.00698	CbGeAlD
Droxidopa—SLC6A2—adrenal gland—hypertension	8.95e-05	0.00687	CbGeAlD
Droxidopa—ADRA2C—medulla oblongata—hypertension	8.56e-05	0.00658	CbGeAlD
Droxidopa—ADRA2A—heart—hypertension	8.48e-05	0.00651	CbGeAlD
Droxidopa—ADRA1A—adrenal gland—hypertension	8.32e-05	0.00639	CbGeAlD
Droxidopa—Dopamine—DBH—hypertension	8.27e-05	0.0428	CrCbGaD
Droxidopa—ADRA2A—decidua—hypertension	8.24e-05	0.00633	CbGeAlD
Droxidopa—ADRB1—central nervous system—hypertension	8.22e-05	0.00632	CbGeAlD
Droxidopa—ADRA2C—adrenal gland—hypertension	7.93e-05	0.00609	CbGeAlD
Droxidopa—SLC6A2—endocrine gland—hypertension	7.76e-05	0.00596	CbGeAlD
Droxidopa—Epinephrine—ADRBK1—hypertension	7.7e-05	0.0399	CrCbGaD
Droxidopa—ADRA2A—cortex of kidney—hypertension	7.62e-05	0.00585	CbGeAlD
Droxidopa—Levonordefrin—ADRA2B—hypertension	7.39e-05	0.0382	CrCbGaD
Droxidopa—ADRA2A—cardiac atrium—hypertension	7.25e-05	0.00557	CbGeAlD
Droxidopa—ADRA1A—endocrine gland—hypertension	7.21e-05	0.00554	CbGeAlD
Droxidopa—Aminosalicylic Acid—ALOX5—hypertension	7.19e-05	0.0372	CrCbGaD
Droxidopa—Dizziness—Amiloride—hypertension	7.18e-05	0.00171	CcSEcCtD
Droxidopa—Dizziness—Hydralazine—hypertension	7.18e-05	0.00171	CcSEcCtD
Droxidopa—Shock—Indapamide—hypertension	7.18e-05	0.00171	CcSEcCtD
Droxidopa—Shock—Diltiazem—hypertension	7.18e-05	0.00171	CcSEcCtD
Droxidopa—Confusional state—Fosinopril—hypertension	7.12e-05	0.0017	CcSEcCtD
Droxidopa—Shock—Carvedilol—hypertension	7.11e-05	0.0017	CcSEcCtD
Droxidopa—Syncope—Valsartan—hypertension	7.1e-05	0.00169	CcSEcCtD
Droxidopa—Dizziness—Pindolol—hypertension	7.09e-05	0.00169	CcSEcCtD
Droxidopa—Syncope—Olmesartan—hypertension	7.06e-05	0.00168	CcSEcCtD
Droxidopa—Shock—Doxazosin—hypertension	7.03e-05	0.00168	CcSEcCtD
Droxidopa—Headache—Candesartan—hypertension	7.03e-05	0.00168	CcSEcCtD
Droxidopa—Confusional state—Nifedipine—hypertension	7.02e-05	0.00168	CcSEcCtD
Droxidopa—Arrhythmia—Perindopril—hypertension	7e-05	0.00167	CcSEcCtD
Droxidopa—Confusional state—Verapamil—hypertension	6.99e-05	0.00167	CcSEcCtD
Droxidopa—SLC6A2—central nervous system—hypertension	6.99e-05	0.00537	CbGeAlD
Droxidopa—Arrhythmia—Irbesartan—hypertension	6.98e-05	0.00166	CcSEcCtD
Droxidopa—Dizziness—Quinapril—hypertension	6.97e-05	0.00166	CcSEcCtD
Droxidopa—Loss of consciousness—Valsartan—hypertension	6.95e-05	0.00166	CcSEcCtD
Droxidopa—Shock—Fosinopril—hypertension	6.95e-05	0.00166	CcSEcCtD
Droxidopa—Headache—Methyldopa—hypertension	6.93e-05	0.00165	CcSEcCtD
Droxidopa—Arrhythmia—Hydrochlorothiazide—hypertension	6.92e-05	0.00165	CcSEcCtD
Droxidopa—Loss of consciousness—Olmesartan—hypertension	6.92e-05	0.00165	CcSEcCtD
Droxidopa—Shock—Eplerenone—hypertension	6.9e-05	0.00165	CcSEcCtD
Droxidopa—Nausea—Bepridil—hypertension	6.9e-05	0.00165	CcSEcCtD
Droxidopa—Dizziness—Benazepril—hypertension	6.86e-05	0.00164	CcSEcCtD
Droxidopa—Shock—Nifedipine—hypertension	6.85e-05	0.00163	CcSEcCtD
Droxidopa—ADRA2A—medulla oblongata—hypertension	6.83e-05	0.00525	CbGeAlD
Droxidopa—Dizziness—Nadolol—hypertension	6.83e-05	0.00163	CcSEcCtD
Droxidopa—Nausea—Penbutolol—hypertension	6.83e-05	0.00163	CcSEcCtD
Droxidopa—Urinary tract infection—Ramipril—hypertension	6.82e-05	0.00163	CcSEcCtD
Droxidopa—Shock—Verapamil—hypertension	6.82e-05	0.00163	CcSEcCtD
Droxidopa—Arrhythmia—Furosemide—hypertension	6.81e-05	0.00162	CcSEcCtD
Droxidopa—Headache—Hydralazine—hypertension	6.8e-05	0.00162	CcSEcCtD
Droxidopa—Headache—Amiloride—hypertension	6.8e-05	0.00162	CcSEcCtD
Droxidopa—Feeling abnormal—Metoprolol—hypertension	6.77e-05	0.00161	CcSEcCtD
Droxidopa—Feeling abnormal—Guanabenz—hypertension	6.77e-05	0.00161	CcSEcCtD
Droxidopa—Syncope—Clonidine—hypertension	6.76e-05	0.00161	CcSEcCtD
Droxidopa—Arrhythmia—Betaxolol—hypertension	6.74e-05	0.00161	CcSEcCtD
Droxidopa—Dizziness—Isradipine—hypertension	6.73e-05	0.0016	CcSEcCtD
Droxidopa—Headache—Pindolol—hypertension	6.71e-05	0.0016	CcSEcCtD
Droxidopa—Dizziness—Guanfacine—hypertension	6.7e-05	0.0016	CcSEcCtD
Droxidopa—Dizziness—Nicardipine—hypertension	6.68e-05	0.00159	CcSEcCtD
Droxidopa—Nausea—Candesartan—hypertension	6.66e-05	0.00159	CcSEcCtD
Droxidopa—Loss of consciousness—Clonidine—hypertension	6.63e-05	0.00158	CcSEcCtD
Droxidopa—Dizziness—Metolazone—hypertension	6.6e-05	0.00157	CcSEcCtD
Droxidopa—Dizziness—Felodipine—hypertension	6.6e-05	0.00157	CcSEcCtD
Droxidopa—Headache—Quinapril—hypertension	6.6e-05	0.00157	CcSEcCtD
Droxidopa—Syncope—Trandolapril—hypertension	6.6e-05	0.00157	CcSEcCtD
Droxidopa—Dizziness—Spironolactone—hypertension	6.58e-05	0.00157	CcSEcCtD
Droxidopa—Syncope—Enalapril—hypertension	6.57e-05	0.00157	CcSEcCtD
Droxidopa—Nausea—Methyldopa—hypertension	6.57e-05	0.00157	CcSEcCtD
Droxidopa—Arrhythmia—Losartan—hypertension	6.57e-05	0.00157	CcSEcCtD
Droxidopa—ADRA1A—central nervous system—hypertension	6.5e-05	0.00499	CbGeAlD
Droxidopa—Headache—Benazepril—hypertension	6.5e-05	0.00155	CcSEcCtD
Droxidopa—Levonordefrin—SLC6A2—hypertension	6.49e-05	0.0336	CrCbGaD
Droxidopa—Syncope—Telmisartan—hypertension	6.48e-05	0.00155	CcSEcCtD
Droxidopa—Loss of consciousness—Trandolapril—hypertension	6.46e-05	0.00154	CcSEcCtD
Droxidopa—Nausea—Hydralazine—hypertension	6.45e-05	0.00154	CcSEcCtD
Droxidopa—Nausea—Amiloride—hypertension	6.45e-05	0.00154	CcSEcCtD
Droxidopa—Dizziness—Esmolol—hypertension	6.44e-05	0.00154	CcSEcCtD
Droxidopa—Loss of consciousness—Enalapril—hypertension	6.44e-05	0.00154	CcSEcCtD
Droxidopa—Headache—Isradipine—hypertension	6.37e-05	0.00152	CcSEcCtD
Droxidopa—Nausea—Pindolol—hypertension	6.37e-05	0.00152	CcSEcCtD
Droxidopa—Dizziness—Terazosin—hypertension	6.36e-05	0.00152	CcSEcCtD
Droxidopa—Shock—Valsartan—hypertension	6.35e-05	0.00152	CcSEcCtD
Droxidopa—Loss of consciousness—Telmisartan—hypertension	6.35e-05	0.00151	CcSEcCtD
Droxidopa—Headache—Guanfacine—hypertension	6.35e-05	0.00151	CcSEcCtD
Droxidopa—ADRA2A—adrenal gland—hypertension	6.33e-05	0.00486	CbGeAlD
Droxidopa—Headache—Nicardipine—hypertension	6.32e-05	0.00151	CcSEcCtD
Droxidopa—Shock—Olmesartan—hypertension	6.32e-05	0.00151	CcSEcCtD
Droxidopa—Syncope—Captopril—hypertension	6.3e-05	0.0015	CcSEcCtD
Droxidopa—Nausea—Quinapril—hypertension	6.26e-05	0.00149	CcSEcCtD
Droxidopa—Headache—Felodipine—hypertension	6.25e-05	0.00149	CcSEcCtD
Droxidopa—Headache—Metolazone—hypertension	6.25e-05	0.00149	CcSEcCtD
Droxidopa—Hypertension—Telmisartan—hypertension	6.24e-05	0.00149	CcSEcCtD
Droxidopa—Headache—Spironolactone—hypertension	6.23e-05	0.00149	CcSEcCtD
Droxidopa—Confusional state—Clonidine—hypertension	6.21e-05	0.00148	CcSEcCtD
Droxidopa—Dizziness—Acebutolol—hypertension	6.2e-05	0.00148	CcSEcCtD
Droxidopa—ADRA2C—central nervous system—hypertension	6.2e-05	0.00476	CbGeAlD
Droxidopa—Urinary tract infection—Lisinopril—hypertension	6.19e-05	0.00148	CcSEcCtD
Droxidopa—Loss of consciousness—Captopril—hypertension	6.18e-05	0.00147	CcSEcCtD
Droxidopa—Nausea—Benazepril—hypertension	6.16e-05	0.00147	CcSEcCtD
Droxidopa—Dizziness—Labetalol—hypertension	6.14e-05	0.00147	CcSEcCtD
Droxidopa—Nausea—Nadolol—hypertension	6.13e-05	0.00146	CcSEcCtD
Droxidopa—Syncope—Perindopril—hypertension	6.12e-05	0.00146	CcSEcCtD
Droxidopa—Headache—Esmolol—hypertension	6.1e-05	0.00146	CcSEcCtD
Droxidopa—Syncope—Irbesartan—hypertension	6.1e-05	0.00145	CcSEcCtD
Droxidopa—Shock—Clonidine—hypertension	6.06e-05	0.00144	CcSEcCtD
Droxidopa—Syncope—Hydrochlorothiazide—hypertension	6.05e-05	0.00144	CcSEcCtD
Droxidopa—Nausea—Isradipine—hypertension	6.04e-05	0.00144	CcSEcCtD
Droxidopa—Confusional state—Enalapril—hypertension	6.03e-05	0.00144	CcSEcCtD
Droxidopa—Headache—Terazosin—hypertension	6.02e-05	0.00144	CcSEcCtD
Droxidopa—Nausea—Guanfacine—hypertension	6.02e-05	0.00144	CcSEcCtD
Droxidopa—Feeling abnormal—Indapamide—hypertension	6.01e-05	0.00143	CcSEcCtD
Droxidopa—Feeling abnormal—Diltiazem—hypertension	6.01e-05	0.00143	CcSEcCtD
Droxidopa—Loss of consciousness—Perindopril—hypertension	6e-05	0.00143	CcSEcCtD
Droxidopa—Nausea—Nicardipine—hypertension	6e-05	0.00143	CcSEcCtD
Droxidopa—Loss of consciousness—Irbesartan—hypertension	5.98e-05	0.00143	CcSEcCtD
Droxidopa—Feeling abnormal—Carvedilol—hypertension	5.96e-05	0.00142	CcSEcCtD
Droxidopa—Dizziness—Eprosartan—hypertension	5.95e-05	0.00142	CcSEcCtD
Droxidopa—Nausea—Metolazone—hypertension	5.93e-05	0.00141	CcSEcCtD
Droxidopa—Nausea—Felodipine—hypertension	5.93e-05	0.00141	CcSEcCtD
Droxidopa—Loss of consciousness—Hydrochlorothiazide—hypertension	5.93e-05	0.00141	CcSEcCtD
Droxidopa—Nausea—Spironolactone—hypertension	5.91e-05	0.00141	CcSEcCtD
Droxidopa—Shock—Trandolapril—hypertension	5.91e-05	0.00141	CcSEcCtD
Droxidopa—Feeling abnormal—Doxazosin—hypertension	5.89e-05	0.0014	CcSEcCtD
Droxidopa—Hypertension—Perindopril—hypertension	5.89e-05	0.0014	CcSEcCtD
Droxidopa—Syncope—Betaxolol—hypertension	5.89e-05	0.0014	CcSEcCtD
Droxidopa—Shock—Enalapril—hypertension	5.88e-05	0.0014	CcSEcCtD
Droxidopa—Headache—Acebutolol—hypertension	5.87e-05	0.0014	CcSEcCtD
Droxidopa—Hypertension—Irbesartan—hypertension	5.87e-05	0.0014	CcSEcCtD
Droxidopa—Headache—Labetalol—hypertension	5.82e-05	0.00139	CcSEcCtD
Droxidopa—Feeling abnormal—Fosinopril—hypertension	5.82e-05	0.00139	CcSEcCtD
Droxidopa—Shock—Telmisartan—hypertension	5.8e-05	0.00138	CcSEcCtD
Droxidopa—Nausea—Esmolol—hypertension	5.79e-05	0.00138	CcSEcCtD
Droxidopa—Feeling abnormal—Eplerenone—hypertension	5.78e-05	0.00138	CcSEcCtD
Droxidopa—Confusional state—Captopril—hypertension	5.78e-05	0.00138	CcSEcCtD
Droxidopa—Dizziness—Nisoldipine—hypertension	5.78e-05	0.00138	CcSEcCtD
Droxidopa—Dizziness—Amlodipine—hypertension	5.78e-05	0.00138	CcSEcCtD
Droxidopa—Loss of consciousness—Betaxolol—hypertension	5.77e-05	0.00138	CcSEcCtD
Droxidopa—Feeling abnormal—Nifedipine—hypertension	5.74e-05	0.00137	CcSEcCtD
Droxidopa—Syncope—Losartan—hypertension	5.74e-05	0.00137	CcSEcCtD
Droxidopa—Methyldopa—COMT—hypertension	5.74e-05	0.0297	CrCbGaD
Droxidopa—Feeling abnormal—Verapamil—hypertension	5.72e-05	0.00136	CcSEcCtD
Droxidopa—Nausea—Terazosin—hypertension	5.71e-05	0.00136	CcSEcCtD
Droxidopa—Shock—Captopril—hypertension	5.64e-05	0.00135	CcSEcCtD
Droxidopa—Mesalazine—ALOX5—hypertension	5.64e-05	0.0292	CrCbGaD
Droxidopa—Headache—Eprosartan—hypertension	5.64e-05	0.00134	CcSEcCtD
Droxidopa—Arrhythmia—Ramipril—hypertension	5.63e-05	0.00134	CcSEcCtD
Droxidopa—Loss of consciousness—Losartan—hypertension	5.62e-05	0.00134	CcSEcCtD
Droxidopa—Confusional state—Perindopril—hypertension	5.61e-05	0.00134	CcSEcCtD
Droxidopa—Nausea—Acebutolol—hypertension	5.57e-05	0.00133	CcSEcCtD
Droxidopa—Confusional state—Hydrochlorothiazide—hypertension	5.55e-05	0.00132	CcSEcCtD
Droxidopa—Nausea—Labetalol—hypertension	5.52e-05	0.00132	CcSEcCtD
Droxidopa—Arrhythmia—Timolol—hypertension	5.5e-05	0.00131	CcSEcCtD
Droxidopa—ADRA2A—endocrine gland—hypertension	5.49e-05	0.00421	CbGeAlD
Droxidopa—Shock—Perindopril—hypertension	5.48e-05	0.00131	CcSEcCtD
Droxidopa—Headache—Nisoldipine—hypertension	5.47e-05	0.00131	CcSEcCtD
Droxidopa—Headache—Amlodipine—hypertension	5.47e-05	0.00131	CcSEcCtD
Droxidopa—Shock—Irbesartan—hypertension	5.46e-05	0.0013	CcSEcCtD
Droxidopa—Confusional state—Furosemide—hypertension	5.46e-05	0.0013	CcSEcCtD
Droxidopa—Dizziness—Guanabenz—hypertension	5.43e-05	0.0013	CcSEcCtD
Droxidopa—Dizziness—Metoprolol—hypertension	5.43e-05	0.0013	CcSEcCtD
Droxidopa—Shock—Hydrochlorothiazide—hypertension	5.41e-05	0.00129	CcSEcCtD
Droxidopa—Confusional state—Betaxolol—hypertension	5.4e-05	0.00129	CcSEcCtD
Droxidopa—Nausea—Eprosartan—hypertension	5.34e-05	0.00127	CcSEcCtD
Droxidopa—Shock—Furosemide—hypertension	5.33e-05	0.00127	CcSEcCtD
Droxidopa—Feeling abnormal—Olmesartan—hypertension	5.3e-05	0.00126	CcSEcCtD
Droxidopa—Shock—Betaxolol—hypertension	5.27e-05	0.00126	CcSEcCtD
Droxidopa—Confusional state—Losartan—hypertension	5.27e-05	0.00126	CcSEcCtD
Droxidopa—Nausea—Nisoldipine—hypertension	5.19e-05	0.00124	CcSEcCtD
Droxidopa—Nausea—Amlodipine—hypertension	5.19e-05	0.00124	CcSEcCtD
Droxidopa—Headache—Metoprolol—hypertension	5.14e-05	0.00123	CcSEcCtD
Droxidopa—Headache—Guanabenz—hypertension	5.14e-05	0.00123	CcSEcCtD
Droxidopa—Shock—Losartan—hypertension	5.14e-05	0.00123	CcSEcCtD
Droxidopa—Arrhythmia—Lisinopril—hypertension	5.11e-05	0.00122	CcSEcCtD
Droxidopa—Feeling abnormal—Clonidine—hypertension	5.07e-05	0.00121	CcSEcCtD
Droxidopa—Isoetarine—ADRB1—hypertension	4.99e-05	0.0258	CrCbGaD
Droxidopa—Dizziness—Propranolol—hypertension	4.99e-05	0.00119	CcSEcCtD
Droxidopa—Feeling abnormal—Trandolapril—hypertension	4.95e-05	0.00118	CcSEcCtD
Droxidopa—ADRA2A—central nervous system—hypertension	4.94e-05	0.0038	CbGeAlD
Droxidopa—Feeling abnormal—Enalapril—hypertension	4.93e-05	0.00118	CcSEcCtD
Droxidopa—Syncope—Ramipril—hypertension	4.92e-05	0.00117	CcSEcCtD
Droxidopa—Nausea—Metoprolol—hypertension	4.88e-05	0.00116	CcSEcCtD
Droxidopa—Nausea—Guanabenz—hypertension	4.88e-05	0.00116	CcSEcCtD
Droxidopa—Feeling abnormal—Telmisartan—hypertension	4.86e-05	0.00116	CcSEcCtD
Droxidopa—Dizziness—Diltiazem—hypertension	4.83e-05	0.00115	CcSEcCtD
Droxidopa—Dizziness—Indapamide—hypertension	4.83e-05	0.00115	CcSEcCtD
Droxidopa—Loss of consciousness—Ramipril—hypertension	4.82e-05	0.00115	CcSEcCtD
Droxidopa—Syncope—Timolol—hypertension	4.81e-05	0.00115	CcSEcCtD
Droxidopa—Dizziness—Carvedilol—hypertension	4.78e-05	0.00114	CcSEcCtD
Droxidopa—Dizziness—Doxazosin—hypertension	4.73e-05	0.00113	CcSEcCtD
Droxidopa—Feeling abnormal—Captopril—hypertension	4.73e-05	0.00113	CcSEcCtD
Droxidopa—Loss of consciousness—Timolol—hypertension	4.71e-05	0.00112	CcSEcCtD
Droxidopa—Dizziness—Fosinopril—hypertension	4.67e-05	0.00111	CcSEcCtD
Droxidopa—Dizziness—Eplerenone—hypertension	4.64e-05	0.00111	CcSEcCtD
Droxidopa—Aminosalicylic Acid—MPO—hypertension	4.63e-05	0.024	CrCbGaD
Droxidopa—Hypertension—Timolol—hypertension	4.63e-05	0.0011	CcSEcCtD
Droxidopa—Dizziness—Nifedipine—hypertension	4.61e-05	0.0011	CcSEcCtD
Droxidopa—Feeling abnormal—Perindopril—hypertension	4.59e-05	0.00109	CcSEcCtD
Droxidopa—Dizziness—Verapamil—hypertension	4.59e-05	0.00109	CcSEcCtD
Droxidopa—Levonordefrin—ADRA1A—hypertension	4.57e-05	0.0237	CrCbGaD
Droxidopa—Feeling abnormal—Irbesartan—hypertension	4.57e-05	0.00109	CcSEcCtD
Droxidopa—Headache—Indapamide—hypertension	4.57e-05	0.00109	CcSEcCtD
Droxidopa—Headache—Diltiazem—hypertension	4.57e-05	0.00109	CcSEcCtD
Droxidopa—Feeling abnormal—Hydrochlorothiazide—hypertension	4.54e-05	0.00108	CcSEcCtD
Droxidopa—Headache—Carvedilol—hypertension	4.53e-05	0.00108	CcSEcCtD
Droxidopa—Confusional state—Ramipril—hypertension	4.52e-05	0.00108	CcSEcCtD
Droxidopa—Nausea—Propranolol—hypertension	4.48e-05	0.00107	CcSEcCtD
Droxidopa—Headache—Doxazosin—hypertension	4.48e-05	0.00107	CcSEcCtD
Droxidopa—Syncope—Lisinopril—hypertension	4.46e-05	0.00106	CcSEcCtD
Droxidopa—Feeling abnormal—Furosemide—hypertension	4.46e-05	0.00106	CcSEcCtD
Droxidopa—Headache—Fosinopril—hypertension	4.42e-05	0.00106	CcSEcCtD
Droxidopa—Feeling abnormal—Betaxolol—hypertension	4.42e-05	0.00105	CcSEcCtD
Droxidopa—Confusional state—Timolol—hypertension	4.41e-05	0.00105	CcSEcCtD
Droxidopa—Shock—Ramipril—hypertension	4.41e-05	0.00105	CcSEcCtD
Droxidopa—Headache—Eplerenone—hypertension	4.4e-05	0.00105	CcSEcCtD
Droxidopa—Norepinephrine—ADRA2B—hypertension	4.38e-05	0.0227	CrCbGaD
Droxidopa—Loss of consciousness—Lisinopril—hypertension	4.37e-05	0.00104	CcSEcCtD
Droxidopa—Headache—Nifedipine—hypertension	4.36e-05	0.00104	CcSEcCtD
Droxidopa—Headache—Verapamil—hypertension	4.34e-05	0.00104	CcSEcCtD
Droxidopa—Nausea—Indapamide—hypertension	4.33e-05	0.00103	CcSEcCtD
Droxidopa—Nausea—Diltiazem—hypertension	4.33e-05	0.00103	CcSEcCtD
Droxidopa—Shock—Timolol—hypertension	4.31e-05	0.00103	CcSEcCtD
Droxidopa—Feeling abnormal—Losartan—hypertension	4.3e-05	0.00103	CcSEcCtD
Droxidopa—Nausea—Carvedilol—hypertension	4.29e-05	0.00102	CcSEcCtD
Droxidopa—Dizziness—Valsartan—hypertension	4.27e-05	0.00102	CcSEcCtD
Droxidopa—Dizziness—Olmesartan—hypertension	4.25e-05	0.00101	CcSEcCtD
Droxidopa—Nausea—Doxazosin—hypertension	4.25e-05	0.00101	CcSEcCtD
Droxidopa—Isoetarine—ADRB2—hypertension	4.2e-05	0.0217	CrCbGaD
Droxidopa—Nausea—Fosinopril—hypertension	4.19e-05	0.001	CcSEcCtD
Droxidopa—Nausea—Eplerenone—hypertension	4.17e-05	0.000994	CcSEcCtD
Droxidopa—Nausea—Nifedipine—hypertension	4.14e-05	0.000987	CcSEcCtD
Droxidopa—Nausea—Verapamil—hypertension	4.12e-05	0.000983	CcSEcCtD
Droxidopa—Confusional state—Lisinopril—hypertension	4.09e-05	0.000977	CcSEcCtD
Droxidopa—Dizziness—Clonidine—hypertension	4.07e-05	0.000971	CcSEcCtD
Droxidopa—Headache—Valsartan—hypertension	4.05e-05	0.000965	CcSEcCtD
Droxidopa—Headache—Olmesartan—hypertension	4.03e-05	0.00096	CcSEcCtD
Droxidopa—Shock—Lisinopril—hypertension	4e-05	0.000953	CcSEcCtD
Droxidopa—Epinephrine—ADRA2B—hypertension	3.98e-05	0.0206	CrCbGaD
Droxidopa—Dizziness—Trandolapril—hypertension	3.97e-05	0.000947	CcSEcCtD
Droxidopa—Dizziness—Enalapril—hypertension	3.95e-05	0.000943	CcSEcCtD
Droxidopa—Dizziness—Telmisartan—hypertension	3.9e-05	0.00093	CcSEcCtD
Droxidopa—Headache—Clonidine—hypertension	3.86e-05	0.00092	CcSEcCtD
Droxidopa—Norepinephrine—SLC6A2—hypertension	3.85e-05	0.0199	CrCbGaD
Droxidopa—Nausea—Valsartan—hypertension	3.84e-05	0.000915	CcSEcCtD
Droxidopa—Nausea—Olmesartan—hypertension	3.82e-05	0.000911	CcSEcCtD
Droxidopa—Dizziness—Captopril—hypertension	3.79e-05	0.000905	CcSEcCtD
Droxidopa—Headache—Trandolapril—hypertension	3.76e-05	0.000897	CcSEcCtD
Droxidopa—Headache—Enalapril—hypertension	3.75e-05	0.000893	CcSEcCtD
Droxidopa—Headache—Telmisartan—hypertension	3.69e-05	0.000881	CcSEcCtD
Droxidopa—Feeling abnormal—Ramipril—hypertension	3.69e-05	0.00088	CcSEcCtD
Droxidopa—Dizziness—Perindopril—hypertension	3.68e-05	0.000878	CcSEcCtD
Droxidopa—Dizziness—Irbesartan—hypertension	3.67e-05	0.000875	CcSEcCtD
Droxidopa—Nausea—Clonidine—hypertension	3.66e-05	0.000872	CcSEcCtD
Droxidopa—Methyldopa—ADRA2A—hypertension	3.66e-05	0.0189	CrCbGaD
Droxidopa—Dizziness—Hydrochlorothiazide—hypertension	3.64e-05	0.000868	CcSEcCtD
Droxidopa—Mesalazine—MPO—hypertension	3.63e-05	0.0188	CrCbGaD
Droxidopa—Feeling abnormal—Timolol—hypertension	3.61e-05	0.000861	CcSEcCtD
Droxidopa—Headache—Captopril—hypertension	3.59e-05	0.000857	CcSEcCtD
Droxidopa—Dopamine—SLC6A2—hypertension	3.58e-05	0.0185	CrCbGaD
Droxidopa—Dizziness—Furosemide—hypertension	3.58e-05	0.000854	CcSEcCtD
Droxidopa—Nausea—Trandolapril—hypertension	3.57e-05	0.000851	CcSEcCtD
Droxidopa—Nausea—Enalapril—hypertension	3.55e-05	0.000847	CcSEcCtD
Droxidopa—Dizziness—Betaxolol—hypertension	3.54e-05	0.000845	CcSEcCtD
Droxidopa—Nausea—Telmisartan—hypertension	3.5e-05	0.000836	CcSEcCtD
Droxidopa—Headache—Perindopril—hypertension	3.49e-05	0.000832	CcSEcCtD
Droxidopa—Headache—Irbesartan—hypertension	3.48e-05	0.000829	CcSEcCtD
Droxidopa—Dizziness—Losartan—hypertension	3.45e-05	0.000824	CcSEcCtD
Droxidopa—Headache—Hydrochlorothiazide—hypertension	3.45e-05	0.000822	CcSEcCtD
Droxidopa—Nausea—Captopril—hypertension	3.41e-05	0.000813	CcSEcCtD
Droxidopa—Headache—Furosemide—hypertension	3.39e-05	0.000809	CcSEcCtD
Droxidopa—Headache—Betaxolol—hypertension	3.36e-05	0.000801	CcSEcCtD
Droxidopa—Feeling abnormal—Lisinopril—hypertension	3.35e-05	0.000798	CcSEcCtD
Droxidopa—Nausea—Perindopril—hypertension	3.31e-05	0.000789	CcSEcCtD
Droxidopa—Nausea—Irbesartan—hypertension	3.3e-05	0.000786	CcSEcCtD
Droxidopa—Headache—Losartan—hypertension	3.27e-05	0.00078	CcSEcCtD
Droxidopa—Nausea—Hydrochlorothiazide—hypertension	3.27e-05	0.00078	CcSEcCtD
Droxidopa—Levonordefrin—ADRA2A—hypertension	3.24e-05	0.0168	CrCbGaD
Droxidopa—Mesalazine—PPARG—hypertension	3.23e-05	0.0167	CrCbGaD
Droxidopa—Nausea—Furosemide—hypertension	3.22e-05	0.000767	CcSEcCtD
Droxidopa—Nausea—Betaxolol—hypertension	3.18e-05	0.000759	CcSEcCtD
Droxidopa—Nausea—Losartan—hypertension	3.1e-05	0.00074	CcSEcCtD
Droxidopa—Aminosalicylic Acid—PTGS1—hypertension	3.04e-05	0.0157	CrCbGaD
Droxidopa—Dizziness—Ramipril—hypertension	2.96e-05	0.000706	CcSEcCtD
Droxidopa—Dizziness—Timolol—hypertension	2.89e-05	0.000691	CcSEcCtD
Droxidopa—Headache—Ramipril—hypertension	2.81e-05	0.000669	CcSEcCtD
Droxidopa—Dopamine—COMT—hypertension	2.8e-05	0.0145	CrCbGaD
Droxidopa—Headache—Timolol—hypertension	2.74e-05	0.000654	CcSEcCtD
Droxidopa—Norepinephrine—ADRA1A—hypertension	2.71e-05	0.014	CrCbGaD
Droxidopa—Dizziness—Lisinopril—hypertension	2.69e-05	0.000641	CcSEcCtD
Droxidopa—Nausea—Ramipril—hypertension	2.66e-05	0.000634	CcSEcCtD
Droxidopa—Nausea—Timolol—hypertension	2.6e-05	0.00062	CcSEcCtD
Droxidopa—Headache—Lisinopril—hypertension	2.54e-05	0.000607	CcSEcCtD
Droxidopa—Epinephrine—ADRA1A—hypertension	2.46e-05	0.0127	CrCbGaD
Droxidopa—Nausea—Lisinopril—hypertension	2.41e-05	0.000575	CcSEcCtD
Droxidopa—Mesalazine—PTGS1—hypertension	2.38e-05	0.0123	CrCbGaD
Droxidopa—L-DOPA—DRD3—hypertension	2.11e-05	0.0109	CrCbGaD
Droxidopa—Dopamine—HTR7—hypertension	2.08e-05	0.0108	CrCbGaD
Droxidopa—Isoprenaline—ADRB1—hypertension	2.07e-05	0.0107	CrCbGaD
Droxidopa—Dopamine—DRD3—hypertension	1.96e-05	0.0101	CrCbGaD
Droxidopa—Norepinephrine—ADRA2A—hypertension	1.92e-05	0.00993	CrCbGaD
Droxidopa—Norepinephrine—ADRB1—hypertension	1.92e-05	0.00992	CrCbGaD
Droxidopa—Dopamine—SLC6A3—hypertension	1.82e-05	0.00942	CrCbGaD
Droxidopa—Dopamine—ADRB1—hypertension	1.78e-05	0.00923	CrCbGaD
Droxidopa—Epinephrine—ADRA2A—hypertension	1.74e-05	0.00901	CrCbGaD
Droxidopa—Isoprenaline—ADRB2—hypertension	1.74e-05	0.00901	CrCbGaD
Droxidopa—Epinephrine—ADRB1—hypertension	1.74e-05	0.009	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—hypertension	1.74e-05	0.00898	CrCbGaD
Droxidopa—Epinephrine—TNF—hypertension	1.65e-05	0.00854	CrCbGaD
Droxidopa—Norepinephrine—ADRB2—hypertension	1.61e-05	0.00835	CrCbGaD
Droxidopa—Isoprenaline—CYP1A1—hypertension	1.49e-05	0.00773	CrCbGaD
Droxidopa—Epinephrine—ADRB2—hypertension	1.46e-05	0.00757	CrCbGaD
Droxidopa—Norepinephrine—DRD2—hypertension	1.46e-05	0.00754	CrCbGaD
Droxidopa—L-DOPA—DRD2—hypertension	1.46e-05	0.00754	CrCbGaD
Droxidopa—Mesalazine—PTGS2—hypertension	1.36e-05	0.00705	CrCbGaD
Droxidopa—Dopamine—SLC6A4—hypertension	1.36e-05	0.00705	CrCbGaD
Droxidopa—Dopamine—DRD2—hypertension	1.35e-05	0.00701	CrCbGaD
Droxidopa—ADRA1A—Signaling Pathways—CAV1—hypertension	4.49e-07	8.99e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOA1—hypertension	4.48e-07	8.97e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—hypertension	4.45e-07	8.92e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KDR—hypertension	4.44e-07	8.89e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—INS—hypertension	4.43e-07	8.87e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PDGFB—hypertension	4.4e-07	8.81e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SERPINE1—hypertension	4.39e-07	8.8e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARG—hypertension	4.39e-07	8.78e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—hypertension	4.38e-07	8.77e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGFR1—hypertension	4.38e-07	8.77e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—INS—hypertension	4.36e-07	8.73e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—hypertension	4.36e-07	8.72e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SERPINE1—hypertension	4.35e-07	8.72e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—RELA—hypertension	4.33e-07	8.68e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—hypertension	4.33e-07	8.66e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HIF1A—hypertension	4.31e-07	8.63e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—INS—hypertension	4.3e-07	8.61e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SERPINE1—hypertension	4.3e-07	8.61e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGT—hypertension	4.3e-07	8.6e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—hypertension	4.29e-07	8.58e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—hypertension	4.28e-07	8.58e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT2—hypertension	4.28e-07	8.57e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—AKT1—hypertension	4.28e-07	8.56e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRKCB—hypertension	4.27e-07	8.56e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FN1—hypertension	4.27e-07	8.56e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—F2—hypertension	4.27e-07	8.56e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—hypertension	4.26e-07	8.53e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FGF2—hypertension	4.25e-07	8.52e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MTOR—hypertension	4.25e-07	8.51e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—hypertension	4.25e-07	8.5e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RHOA—hypertension	4.24e-07	8.49e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CALM1—hypertension	4.23e-07	8.46e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—hypertension	4.22e-07	8.44e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FGF2—hypertension	4.22e-07	8.44e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT2—hypertension	4.21e-07	8.43e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—hypertension	4.21e-07	8.43e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOE—hypertension	4.21e-07	8.43e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RHOA—hypertension	4.2e-07	8.41e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PIK3R1—hypertension	4.2e-07	8.4e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—hypertension	4.2e-07	8.4e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—hypertension	4.19e-07	8.4e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOTCH1—hypertension	4.18e-07	8.37e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CAV1—hypertension	4.17e-07	8.35e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOA1—hypertension	4.16e-07	8.33e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGF2—hypertension	4.16e-07	8.33e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—hypertension	4.16e-07	8.32e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PIK3R1—hypertension	4.16e-07	8.32e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RHOA—hypertension	4.15e-07	8.3e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KDR—hypertension	4.13e-07	8.26e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—hypertension	4.1e-07	8.22e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PIK3R1—hypertension	4.1e-07	8.22e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—hypertension	4.08e-07	8.18e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SERPINE1—hypertension	4.07e-07	8.14e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SERPINE1—hypertension	4e-07	8.01e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRKCB—hypertension	3.97e-07	7.95e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FN1—hypertension	3.97e-07	7.95e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—F2—hypertension	3.97e-07	7.95e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—RELA—hypertension	3.95e-07	7.91e-06	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AKT1—hypertension	3.95e-07	7.9e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—hypertension	3.94e-07	7.9e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGF2—hypertension	3.94e-07	7.88e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RHOA—hypertension	3.92e-07	7.86e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—RELA—hypertension	3.91e-07	7.83e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—hypertension	3.89e-07	7.79e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOTCH1—hypertension	3.89e-07	7.78e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—hypertension	3.88e-07	7.78e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PIK3R1—hypertension	3.88e-07	7.77e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—hypertension	3.88e-07	7.77e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGF2—hypertension	3.88e-07	7.76e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MTOR—hypertension	3.87e-07	7.75e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—INS—hypertension	3.87e-07	7.75e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—RELA—hypertension	3.86e-07	7.73e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RHOA—hypertension	3.86e-07	7.73e-06	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—hypertension	3.85e-07	7.7e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MTOR—hypertension	3.84e-07	7.68e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—hypertension	3.82e-07	7.65e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PIK3R1—hypertension	3.82e-07	7.65e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—hypertension	3.81e-07	7.63e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MTOR—hypertension	3.79e-07	7.58e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PIK3R1—hypertension	3.77e-07	7.55e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—hypertension	3.77e-07	7.55e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—hypertension	3.74e-07	7.5e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT2—hypertension	3.74e-07	7.49e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—hypertension	3.73e-07	7.46e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—hypertension	3.72e-07	7.45e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTEN—hypertension	3.7e-07	7.42e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—hypertension	3.69e-07	7.4e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—hypertension	3.69e-07	7.38e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDKN1A—hypertension	3.68e-07	7.37e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PTEN—hypertension	3.67e-07	7.35e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—RELA—hypertension	3.66e-07	7.32e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—hypertension	3.64e-07	7.29e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—hypertension	3.62e-07	7.24e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—RELA—hypertension	3.6e-07	7.2e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—INS—hypertension	3.6e-07	7.2e-06	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKT1—hypertension	3.6e-07	7.2e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MAPK8—hypertension	3.59e-07	7.19e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MTOR—hypertension	3.58e-07	7.18e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKT1—hypertension	3.58e-07	7.17e-06	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKT1—hypertension	3.56e-07	7.13e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SERPINE1—hypertension	3.56e-07	7.12e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—hypertension	3.54e-07	7.09e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—hypertension	3.54e-07	7.09e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—EP300—hypertension	3.53e-07	7.07e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MTOR—hypertension	3.53e-07	7.06e-06	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—hypertension	3.52e-07	7.05e-06	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKT1—hypertension	3.52e-07	7.04e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—hypertension	3.51e-07	7.02e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EP300—hypertension	3.5e-07	7.01e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—hypertension	3.48e-07	6.97e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT2—hypertension	3.48e-07	6.96e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—hypertension	3.46e-07	6.93e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—hypertension	3.46e-07	6.93e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—hypertension	3.45e-07	6.91e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—hypertension	3.44e-07	6.9e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGF2—hypertension	3.44e-07	6.89e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RHOA—hypertension	3.43e-07	6.87e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SRC—hypertension	3.41e-07	6.82e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PIK3R1—hypertension	3.4e-07	6.8e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—hypertension	3.4e-07	6.8e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—hypertension	3.39e-07	6.79e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—hypertension	3.37e-07	6.74e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDKN1A—hypertension	3.35e-07	6.72e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTEN—hypertension	3.35e-07	6.7e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—hypertension	3.34e-07	6.68e-06	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKT1—hypertension	3.33e-07	6.66e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDKN1A—hypertension	3.32e-07	6.65e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VEGFA—hypertension	3.32e-07	6.64e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTEN—hypertension	3.32e-07	6.64e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SERPINE1—hypertension	3.3e-07	6.61e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—hypertension	3.29e-07	6.59e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDKN1A—hypertension	3.28e-07	6.57e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—hypertension	3.28e-07	6.56e-06	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKT1—hypertension	3.28e-07	6.56e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MAPK8—hypertension	3.27e-07	6.55e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTEN—hypertension	3.27e-07	6.55e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKT1—hypertension	3.27e-07	6.54e-06	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKT1—hypertension	3.25e-07	6.51e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MAPK8—hypertension	3.24e-07	6.49e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKT1—hypertension	3.24e-07	6.48e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—hypertension	3.22e-07	6.45e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MAPK8—hypertension	3.2e-07	6.41e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGF2—hypertension	3.2e-07	6.4e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RELA—hypertension	3.2e-07	6.4e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKT1—hypertension	3.19e-07	6.39e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EP300—hypertension	3.19e-07	6.39e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RHOA—hypertension	3.19e-07	6.38e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EP300—hypertension	3.16e-07	6.33e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—hypertension	3.15e-07	6.32e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PIK3R1—hypertension	3.15e-07	6.32e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MTOR—hypertension	3.13e-07	6.27e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EP300—hypertension	3.12e-07	6.25e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—hypertension	3.12e-07	6.24e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDKN1A—hypertension	3.1e-07	6.22e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SRC—hypertension	3.1e-07	6.21e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTEN—hypertension	3.1e-07	6.2e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SRC—hypertension	3.08e-07	6.16e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—hypertension	3.07e-07	6.14e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDKN1A—hypertension	3.06e-07	6.12e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYC—hypertension	3.05e-07	6.11e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTEN—hypertension	3.05e-07	6.1e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—hypertension	3.05e-07	6.1e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SRC—hypertension	3.04e-07	6.08e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MAPK8—hypertension	3.03e-07	6.07e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VEGFA—hypertension	3.02e-07	6.05e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKT1—hypertension	3.02e-07	6.05e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—hypertension	3.01e-07	6.03e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTEN—hypertension	3.01e-07	6.02e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VEGFA—hypertension	3e-07	6e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—hypertension	2.99e-07	5.98e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MAPK8—hypertension	2.98e-07	5.97e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKT1—hypertension	2.97e-07	5.95e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RELA—hypertension	2.97e-07	5.94e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VEGFA—hypertension	2.96e-07	5.92e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EP300—hypertension	2.95e-07	5.91e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MTOR—hypertension	2.91e-07	5.83e-06	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKT1—hypertension	2.91e-07	5.82e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EP300—hypertension	2.91e-07	5.82e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SRC—hypertension	2.87e-07	5.75e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—EP300—hypertension	2.87e-07	5.74e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—hypertension	2.86e-07	5.73e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SRC—hypertension	2.83e-07	5.66e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—hypertension	2.8e-07	5.6e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VEGFA—hypertension	2.8e-07	5.6e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYC—hypertension	2.78e-07	5.57e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—hypertension	2.77e-07	5.55e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYC—hypertension	2.76e-07	5.52e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VEGFA—hypertension	2.75e-07	5.51e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—hypertension	2.75e-07	5.5e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—hypertension	2.72e-07	5.45e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYC—hypertension	2.72e-07	5.45e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—hypertension	2.72e-07	5.45e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDKN1A—hypertension	2.71e-07	5.43e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—hypertension	2.71e-07	5.43e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTEN—hypertension	2.71e-07	5.42e-06	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKT1—hypertension	2.7e-07	5.41e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—hypertension	2.7e-07	5.4e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—hypertension	2.66e-07	5.33e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—hypertension	2.66e-07	5.33e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MAPK8—hypertension	2.65e-07	5.3e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKT1—hypertension	2.64e-07	5.29e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EP300—hypertension	2.58e-07	5.17e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYC—hypertension	2.57e-07	5.15e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—hypertension	2.57e-07	5.14e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYC—hypertension	2.53e-07	5.07e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—hypertension	2.53e-07	5.07e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—hypertension	2.53e-07	5.06e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDKN1A—hypertension	2.52e-07	5.05e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—hypertension	2.52e-07	5.04e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTEN—hypertension	2.52e-07	5.04e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SRC—hypertension	2.51e-07	5.03e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—hypertension	2.51e-07	5.02e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—hypertension	2.48e-07	4.96e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MAPK8—hypertension	2.46e-07	4.93e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKT1—hypertension	2.45e-07	4.91e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VEGFA—hypertension	2.45e-07	4.9e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EP300—hypertension	2.4e-07	4.8e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SRC—hypertension	2.33e-07	4.67e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—hypertension	2.29e-07	4.59e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—hypertension	2.28e-07	4.57e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VEGFA—hypertension	2.27e-07	4.55e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—hypertension	2.26e-07	4.53e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYC—hypertension	2.25e-07	4.51e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—hypertension	2.24e-07	4.49e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—hypertension	2.23e-07	4.47e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—hypertension	2.2e-07	4.41e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AKT1—hypertension	2.14e-07	4.27e-06	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKT1—hypertension	2.12e-07	4.24e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—hypertension	2.11e-07	4.23e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYC—hypertension	2.09e-07	4.19e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—hypertension	2.09e-07	4.19e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—hypertension	2.09e-07	4.18e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—hypertension	2.08e-07	4.17e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—hypertension	2.07e-07	4.15e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—hypertension	2.05e-07	4.09e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—hypertension	2.05e-07	4.09e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—hypertension	1.94e-07	3.87e-06	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKT1—hypertension	1.93e-07	3.86e-06	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKT1—hypertension	1.91e-07	3.83e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—hypertension	1.9e-07	3.81e-06	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKT1—hypertension	1.89e-07	3.78e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—hypertension	1.85e-07	3.7e-06	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT1—hypertension	1.79e-07	3.57e-06	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT1—hypertension	1.76e-07	3.52e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AKT1—hypertension	1.73e-07	3.47e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—hypertension	1.72e-07	3.44e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—hypertension	1.69e-07	3.39e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—hypertension	1.57e-07	3.15e-06	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT1—hypertension	1.56e-07	3.12e-06	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT1—hypertension	1.45e-07	2.9e-06	CbGpPWpGaD
